Earnings dates and session timing shown here are aggregated from third-party sources, are frequently estimated, and are subject to change or confirmation by the reporting company. Nothing on this site is financial advice.
Parabilis Medicines, Inc. (Ticker: PBLS) is an emerging company at the forefront of the telecommunications sector, dedicated to delivering innovative communication solutions tailored for both residential and commercial markets. The company leverages advanced technologies to enhance connectivity and customer experiences, positioning itself strategically for growth in the rapidly evolving digital landscape. With a strong focus on expanding its infrastructure and maintaining operational excellence, PBLS represents a compelling investment opportunity for institutional investors seeking to capitalize on the burgeoning demand for seamless communication services.
Quotes and fundamental data are delayed and provided for informational purposes only — nothing on this page is financial advice. Figures are as reported by the company and its data providers and may be revised. Estimates reflect analyst consensus at the time of each report.
$31.20
| Quarter | EPS | Revenue | Price move | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Est | Adj | Result | GAAP | Est | Actual | Surprise | 1D Pre | On-Day | 1D Post | |
Q ended Jun 30, 2026 Reported Aug 13, 2026 | $-0.16 | $-2.13 | Miss -1231.3% | — | $16.67M | $148K | -99.1% | 1D Pre+2.6% | On-Day-4.7% | 1D Post+3.9% |
Q ended Mar 31, 2026 Report date n/a | — | — | — | — | — | $0 | — | 1D Pre— | On-Day— | 1D Post— |
Q ended Mar 31, 2025 Report date n/a | ||||||||||
Dashed outlines show the analyst consensus estimate for periods where one was published. Hover or tap a bar for exact figures. Values as reported; not adjusted for splits after the report date.
| — |
| — |
| — |
| — |
| $0 |
| — |
| 1D Pre— |
| On-Day— |
| 1D Post— |